Age better predictor of curable prostate cancer:
This article was originally published in Clinica
A man's age could be a better predictor of prostate cancer outcome than prostate specific antigen (PSA) levels. In a study of 492 men who underwent surgery for prostate cancer, researchers from the Johns Hopkins University in Baltimore found that the probability of having a curable cancer depended more on age than on increasing PSA level. The study, published in the January issue of the journal Urology, suggested that early detection efforts in younger men could reduce the number of deaths from the disease.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.